Ann: Notice of Annual General Meeting, page-208

Hard to believe that in Jan 2020, the SP was 20c after Taiwan FDA was announced. Even 20c was disappointing, since that's the ASX IPO price.

As an LTH, I'd prefer a suspension and a clean-up of the company's ethics, to the giant red flag that's been draped over the company by the unjustified self-enrichment of the Board. How about a performance bonus for submitting China NMPA data for trials completed in JANUARY, which they promised would be submitted by end of APRIL? This outfit is shameless. The Board is not on the same team as the shareholders. We are the sacrificial lambs, they vote themselves a Lamborghini.

Unfortunately, since voting has already begun, I'd be astonished if Yacov changed any of the proposed resolutions. But what we can do is muster every vote AGAINST.